Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Neisseria meningitidis is responsible for the seasonal burden and recurrent epidemics of meningitis in an area of sub-Saharan Africa known as the meningitis belt. Historically, the majority of the cases in the meningitis belt are caused by serogroup A meningococci. Serogroup C meningococci were resp...
Main Authors: | Xie, O, Pollard, A, Mueller, J, Norheim, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
by: Micoli, F, et al.
Published: (2013) -
Serogroup B meningococcal vaccines-an unfinished story.
by: Sadarangani, M, et al.
Published: (2010) -
Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01) -
Serogroup X in Meningococcal Disease, Western Kenya
by: Sadiki Materu, et al.
Published: (2007-06-01) -
Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017-05-01)